Quotes 5-day view End-of-day quote Tokyo Stock Exchange
09/14/2020
09/15/2020
09/16/2020
09/17/2020
09/18/2020
Date
4712
4768
4778
4819
4711
Last
1247200
1373900
1469400
1318200
3248800
Volume
-1.46% +1.19% +0.21% +0.86% -2.24% Change
Sales 2020
763 B 7 280 M 7 280 M
Net income 2020
214 B 2 046 M 2 046 M
Net cash position 2020
415 B 3 964 M 3 964 M
P/E ratio 2020
37,1x
Yield 2020
1,08%
Sales 2021
838 B 8 000 M 8 000 M
Net income 2021
249 B 2 380 M 2 380 M
Net cash position 2021
491 B 4 689 M 4 689 M
P/E ratio 2021
31,5x
Yield 2021
1,35%
Capitalization
7 921 B 75 598 M 75 586 M
EV / Sales 2020
9,84x
EV / Sales 2021
8,86x
Nbr of Employees
7 394
Free-Float
37,7%
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (50.5% of net sales), bones and joints diseases treatment (34.3%), and kidney diseases (6.9%).
Net sales are distributed geographically as follows: Japan (75.8%), Switzerland (20.8%) and other (3.4%).
Notations Surperformance© of Chugai Pharmaceutical Co., Ltd.
Trading Rating : Investor Rating :
All news about CHUGAI PHARMACEUTICAL CO., LTD.
News in other languages on CHUGAI PHARMACEUTICAL CO., LTD.
Chart CHUGAI PHARMACEUTICAL CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD.
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
12
Average target price
4 956,42 JPY
Last Close Price
4 819,00 JPY
Spread / Highest target
45,3%
Spread / Average Target
2,85%
Spread / Lowest Target
-27,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
